Walgreens Boots Alliance, Inc. (NASDAQ:WBA) shares edged slightly higher on Tuesday. The firm’s specialty pharmacy arm ...

Walgreens Specialty Pharmacy has expanded its limited distribution drug (LDD) network to now include 265 products, placing it ...

Walgreens Specialty Pharmacy, which earned $25.9 billion last year from U.S. prescription revenue, has expanded its limited distribution drug portfolio to 265 medications, the company said Aug. 19. ...

Walgreens Specialty Pharmacy has more than 1,500 specialty-trained pharmacists, 5,000 patient advocacy support team members and ten dedicated Specialty360 teams that support all specialty ...

Walgreens Boots Alliance (NASDAQ:WBA) has expanded its specialty pharmacy services with a unit dedicated to gene and cell therapy services, the company announced late Wednesday. Effective Aug. 1 ...

Walgreens (WBA) is standing up a new specialty pharmacy segment to compete in an increasingly crowded pharmacy benefits manager (PBM) and specialty pharmacy space. The company announced Thursday ...

Walgreens on Thursday said it will start to work directly with drugmakers to bring cell and gene therapies to U.S. patients as part of a broader expansion of its specialty pharmacy services.

Walgreens is closing a specialty location in Chicago in June as part of the chain's plan to close more than 1,000 underperforming stores. Find out more.

Shields partners with about 80 U.S. health systems, representing about 1,000 hospitals, to integrate specialty pharmacy services, according to a Sept. 20 news release from Walgreens Boots Alliance.

DEERFIELD, Ill. — Walgreens said this week that it will acquire Option Care, Buffalo Grove, Ill., by merger. Option Care provides specialty pharmacy and home infusion services from a national ...

Walgreens Boots Alliance is investing $970 million for a majority stake in a specialty pharmacy company that works with hospitals and health systems to set up and run their own on-site specialty ...